{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:30:45Z","timestamp":1791844245436,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/dote\/dow020","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T09:17:13Z","timestamp":1490779033000},"page":"1-9","source":"Crossref","is-referenced-by-count":152,"title":["Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"30","author":[{"given":"D. A.","family":"Leiman","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Riff","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Icahn School of Medicine at Mt. Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Center for Evidence-based Practice"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Metz","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. W.","family":"Falk","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"French","sequence":"additional","affiliation":[{"name":"Center for Evidence-based Practice"},{"name":"Department of Biostatistics and Epidemiology"},{"name":"Leonard Davis Institute of Health Economics"},{"name":"Center for Clinical Epidemiology and Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Umscheid","sequence":"additional","affiliation":[{"name":"Center for Evidence-based Practice"},{"name":"Department of Biostatistics and Epidemiology"},{"name":"Leonard Davis Institute of Health Economics"},{"name":"Center for Clinical Epidemiology and Biostatistics"},{"name":"Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u00a0D.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"},{"name":"Department of Biostatistics and Epidemiology"},{"name":"Leonard Davis Institute of Health Economics"},{"name":"Center for Clinical Epidemiology and Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"key\n\t\t\t\t20180524063602_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180524063602_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MOG.0b013e32833ae2be","article-title":"Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors","volume":"26","author":"Hershcovici","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20180524063602_bib5","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ajg.2009.50","article-title":"Proton pump inhibitor failure\u2013what are the therapeutic options?","volume":"104","author":"Fass","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/apt.12857","article-title":"Gaviscon double action liquid (antacid and alginate) is more effective than antacid in controlling postprandial oesphageal acid exposure in GERD patients: a double-blind crossover-study","volume":"40","author":"de Ruigh","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib7","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cgh.2013.04.046","article-title":"An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease","volume":"11","author":"Rohof","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180524063602_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2013.06.008","article-title":"Capping the gastric acid pocket to reduce postprandial acid gastroesophageal reflux","volume":"11","author":"Sifrim","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180524063602_bib9","article-title":"Chapter 8: Assessing Risk of Bias in Included Studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"key\n\t\t\t\t20180524063602_bib10","volume-title":"The Esophagus","author":"Katz","year":"2012","edition":"5th edn"},{"key":"key\n\t\t\t\t20180524063602_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007997209111146","article-title":"Medical treatment of symptomatic hiatus hernia with low-density compounds","volume":"1","author":"Beeley","year":"1972","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180524063602_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(74)92340-X","article-title":"Alginate\/antacid in the reduction of gastro-oesophageal reflux","volume":"303","author":"Stanciu","year":"1974","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180524063602_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2036.1998.00283.x","article-title":"Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastroesophageal reflux","volume":"12","author":"Poynard","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1185\/03007997509114793","article-title":"A double-blind controlled trial of \u2018Gaviscon\u2019in patients with symptomatic gastro-oesophageal reflux","volume":"3","author":"Barnardo","year":"1975","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180524063602_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/030006058000800411","article-title":"A comparative crossover study on the treatment of heartburn and epigastric pain: liquid Gaviscon and a magnesium-aluminium antacid gel","volume":"8","author":"Chevrel","year":"1980","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t20180524063602_bib16","first-page":"48","article-title":"Comparative study of Algicon suspension and magnesium trisilicate mixture in the reatment of reflux dyspepsia of pregnancy","volume":"66","author":"Lang","year":"1989","journal-title":"Br J Clin Pract Suppl"},{"key":"key\n\t\t\t\t20180524063602_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1185\/03007999909114086","article-title":"A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease","volume":"15","author":"Chatfield","year":"1999","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180524063602_bib18","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s10620-006-9284-0","article-title":"A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms","volume":"51","author":"Giannini","year":"2006","journal-title":"Dig Des Sci"},{"key":"key\n\t\t\t\t20180524063602_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3748\/wjg.v12.i5.747","article-title":"Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease","volume":"12","author":"Lai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/apt.12640","article-title":"Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease","volume":"39","author":"Thomas","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/978-3-642-86432-2_242","article-title":"The effect of adding cimetidine to alginate-antacid in treating gastro-esophageal reflux","author":"Bennett","year":"1988","journal-title":"Diseases of the Esophagus: Springer"},{"key":"key\n\t\t\t\t20180524063602_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2036.1998.0284f.x","article-title":"First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid\/alginate liquid: a multicentre study in general practice","volume":"12","author":"Goves","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1442-2050.2011.01276.x","article-title":"Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial","volume":"25","author":"Manabe","year":"2012","journal-title":"Dis Esophagus"},{"key":"key\n\t\t\t\t20180524063602_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-230X-12-18","article-title":"Gaviscon vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial","volume":"12","author":"Pouchain","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.12482","article-title":"Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease","volume":"38","author":"Chiu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2036.2006.03135.x","article-title":"Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies","volume":"25","author":"Tran","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib28","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","article-title":"Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials","volume":"4","author":"Gralnek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180524063602_bib29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","article-title":"Symptomatic reflux disease: the present, the past and the future","volume":"63","author":"Boeckxstaens","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180524063602_bib30","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"van Pinxteren","year":"2006","journal-title":"Cochrane Database System Rev"},{"key":"key\n\t\t\t\t20180524063602_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ajg.2013.132","article-title":"The acid pocket: a target for treatment in reflux disease?","volume":"108","author":"Kahrilas","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180524063602_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0266462399015226","article-title":"Comparison of literature searches on quality and costs for health technology assessment using the MEDLINE and EMBASE databases","volume":"15","author":"Topfer","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"key":"key\n\t\t\t\t20180524063602_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2036.2006.02814.x","article-title":"Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension","volume":"23","author":"Tytgat","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180524063602_bib34","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20180524063602_bib35","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/ajg.2009.49","article-title":"Overutilization of proton pump inhibitors: a review of cost effectiveness and risk [corrected]","volume":"104","author":"Heidelbaugh","year":"2009","journal-title":"Am J Gastroenterol"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/dote\/article-pdf\/30\/5\/1\/24854369\/dow020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T09:30:34Z","timestamp":1719135034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/30\/5\/1\/3092443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,29]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/dow020","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,3,29]]}}}